Angiotensinogen gene polymorphism in acute myocardial infarction patients

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System

Volumn 12, Issue 1, 2011, Pages 42-47

  Mehri, Sounira ^a,b   Mahjoub, Sinda ^b   Farhati, Abdeljelil ^c   Bousaada, Rafik ^c   Ben Arab, Saïda ^b   Baudin, Bruno ^d   Hammami, Mohamed ^a  

^a UNIVERSITY OF MONASTIR   (Tunisia)

^b UNIVERSITY OF TUNIS EL MANAR   (Tunisia)

^c LA RABTA HOSPITAL   (Tunisia)

^d HÔPITAL SAINT ANTOINE   (France)

Author keywords

acute myocardial infarction; angiotensinogen polymorphism; coronary artery disease; coronary stenosis; critical arterial occlusion

Indexed keywords

ANGIOTENSINOGEN; GENOMIC DNA; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ACUTE HEART INFARCTION; ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; DISEASE SEVERITY; DNA EXTRACTION; ELECTROCARDIOGRAM; ENZYME ASSAY; FAMILY HISTORY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; GLUCOSE BLOOD LEVEL; HEART CATHETERIZATION; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; POLYMERASE CHAIN REACTION; QUESTIONNAIRE; TREATMENT INDICATION; TRIACYLGLYCEROL BLOOD LEVEL; UNIVARIATE ANALYSIS;

ALLELES; ANGIOTENSINOGEN; CORONARY OCCLUSION; CORONARY STENOSIS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 79952559280     PISSN: 14703203     EISSN: None     Source Type: Journal    
DOI: 10.1177/1470320310376425     Document Type: Article

References (31)

1. Bader M, Wagner J, Lee MA, et al. The role of the reninangiotensin system in cardiovascular disease. Hypertens Res 1994; 17: 1-16. (Pubitemid 24144710)
2. Zhu X, Yan D, Cooper RS, et al. Linkage disequilibrium and haplotype diversity in the genes of the renin-angiotensin system: findings from the family blood pressure program. Genome Res 2003; 13: 173-81. (Pubitemid 36575766)
3. Jeunemaitre X, Soubrier F, Kotelevtsev YV, et al. Molecular basis of human hypertension: role of angiotensinogen. Cell 1992; 71: 169-80.
4. Jeunemaitre X, Ledru F, Battaglia S, et al. Genetic polymorphisms of the renin-angiotensin system and angiographic extent and severity of coronary artery disease: the CORGENE study. Hum Genet 1997; 99: 66-73. (Pubitemid 26419858)
5. Rodriguez-Perez JC, Rodriguez-Esparragon F, Hernandez- Perera O, et al. Association of angiotensinogen M235T and A(-6)G gene polymorphisms with coronary heart disease with independence of essential hypertension: the PROCAGENE study. Prospective Cardiac Gene. J Am Coll Cardiol 2001; 37: 1536-42.
6. Sethi AA, Tybjaerg-Hansen A, Gronholdt ML, et al. Angiotensinogen mutations and risk for ischemic heart disease, myocardial infarction, and ischemic cerebrovascular disease. Six case-control studies from the Copenhagen City Heart Study. Ann Intern Med 2001; 134: 941-54. (Pubitemid 32466233)
7. Nair KG, Shalia KK, Ashavaid TF, et al. Coronary heart disease, hypertension, and angiotensinogen gene variants in Indian population. J Clin Lab Anal 2003; 17: 141-6. (Pubitemid 37128652)
8. Gardemann A, Stricker J, Humme J, et al. Angiotensinogen T174M and M235T gene polymorphisms are associated with the extent of coronary atherosclerosis. Atherosclerosis 1999; 145: 309-14. (Pubitemid 29359139)
9. van der Wal AC, Becker AE, van der Loos CM, et al. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 1994; 89: 36-44. (Pubitemid 24026469)
10. Pfeffer M. Enhancing cardiac protection after myocardial infarction: rationale for newer clinical trials of angiotensin receptor blockers. Am Heart J 2000; 139: S23-S28. (Pubitemid 30041753)
11. Gensini GG. Coronary arteriography. In: Braunwald E, editor. Heart disease Philadelphia: Saunders 1980; 352-353.
12. Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 1983; 51: 606. (Pubitemid 13187192)
13. Smaoui M, Hammami S, Chaaba R, et al. Lipids and lipoprotein(a) concentrations in Tunisian type 2 diabetic patients; Relationship to glycemic control and coronary heart disease. J Diabetes Complications 2004; 18: 258-63. (Pubitemid 39165431)
14. Russ AP, Maerz W, Ruzicka V, et al. Rapid detection of the hypertension-associated Met235YThr allele of the human angiotensinogen gene. Hum Mol Genet 1993; 2: 609-10. (Pubitemid 23140035)
15. Staessen JA, Kuznetsova T, Wang JG, et al. M235T angiotensinogen gene polymorphism and cardiovascular renal risk. J Hypertens 1999; 17: 9-17. (Pubitemid 29086182)
16. Kunz R, Kreutz R, Beige J, et al. Association between the angiotensinogen 235T-variant and essential hypertension in whites: a systematic review and methodological appraisal. Hypertension 1997; 30: 1331-7. (Pubitemid 27528071)
17. Sethi AA, Nordestgaard BG, Tybjaerg-Hansen A. Angiotensinogen gene polymorphism, plasma angiotensinogen, and risk of hypertension and ischemic heart disease: a metaanalysis. Arterioscler Thromb Vasc Biol 2003; 23: 1269-75. (Pubitemid 36871283)
18. Mondry A, Loh M, Liu P, et al. Polymorphisms of the insertion/ deletion ACE and M235T AGT genes and hypertension: surprising new findings and meta-analysis of data. BMC Nephrol 2005; 6: 1.
19. Gould AB, Green D. Kinetics of the human renin and human substrate reaction. Cardiovasc Res 1971; 5: 86-89.
20. Ishigami T, Umemura S, Iwamoto T, et al. Molecular variant of angiotensinogen gene is associated with coronary atherosclerosis. Circulation 1995; 91: 951-954.
21. Lanz JR, Pereira AC, Lemos PA, et al. Angiotensinogen M235T polymorphism is associated with coronary artery disease severity. Clin Chim Acta 2005; 362: 176-81. (Pubitemid 41597103)
22. Olivieri O, Stranieri C, Girelli D, et al. Homozygosity for angiotensinogen 235T variant increases the risk of myocardial infarction in patients with multi-vessel coronary artery disease. J Hypertens 2001; 19: 879-84. (Pubitemid 32436951)
23. Pereira AC, Mota GF, Cunha RS, et al. Angiotensinogen 235T allele dosage is associated with blood pressure phenotypes. Hypertension 2003; 41: 25-30. (Pubitemid 36056787)
24. Goldenberg I, Moss AJ, Ryan D, et al. Polymorphism in the angiotensinogen gene, hypertension, and ethnic differences in the risk of recurrent coronary events. Hypertension. 2006; 48: 693-9. (Pubitemid 44843874)
25. Reid IA, Morris BJ, Ganong Wj. The renin-angiotensin system. Annu Rev Physiol 1978; 40: 377-410. (Pubitemid 8351313)
26. Luft FC. Cardiac angiotensin is upregulated in the hearts of unstable angina patients. Circ Res 2004; 94: 1530-2. (Pubitemid 38856959)
27. Mancini GB. Role of angiotensin-converting enzyme inhibition in reversal of endothelial dysfunction in coronary artery disease. Am J Med 1998; 105: 40S-47S.
28. Zhang H, Schmeisser A, Garlichs CD, et al. Angiotensin II-induced superoxide anion generation in human vascular endothelial cells: role of membranebound NADH-/NADPH-oxidases. Cardiovasc Res 1999; 44: 215-22. (Pubitemid 29431699)
29. Yao S-K, Ober JC, Krishnaswami A, et al. Endogenous nitric oxide protects against platelet aggregation and cyclic flow variations in stenosed and endothelium injured arteries. Circulation 1992; 86: 1302-9.
30. Kugiyama K, Yasue H, Okumura K, et al. Nitric oxide activity is deficient in spasm arteries of patients with coronary spastic angina. Circulation 1996; 94: 266-72. (Pubitemid 26266108)
31. Yamagishi M, Miyatake K, Tamai J, et al. Intravascular ultrasound detection of atherosclerosis at the site of focal vasospasm in angiographically normal or minimally narrowed coronary segments. J Am Coll Cardiol 1994; 23: 352-7. (Pubitemid 24049364)